ALFA Finder| Revenue growth | 4.51% YoY for continued operations. |
|---|---|
| Margins | EBITDA Margin down to 2.22%; EBIT margins negative in Sugar and consolidated. |
| Demand visibility | Focus on high-growth Country Liquor and value-added pharma-grade sugar. |
Growth
Continued operations Revenue grew 4.51% YoY. Country Liquor segment surged 266.96%, offset by declines in Sugar (-13.84%) and Bio-Fuels (-36.72%).
Outlook
Completed sale of Meerganj Unit on June 18, 2026. Management is focusing on dual-feed ethanol and capacity utilization at Asmoli and Mansurpur.
Risks
Margins under pressure with EBITDA margin at 2.22% vs 2.56% YoY. Significant volatility in Bio-Fuel and Spirit revenues.
Last quarter's promises, checked
Delivered
- Guided Asmoli conversion to dual-feed by June 2025 → delivered 100 KLPD dual-feed facility (= BEAT)
- Guided repayment of long-term loans → delivered ₹15 Cr repaid in Q1 (= BEAT)
- Guided focus on country liquor growth → delivered 45.16% volume increase (= BEAT)
Partly delivered
- Guided sugar realization improvement → delivered ₹40,835/ton vs ₹39,153/ton (+4.5%) (= PARTIAL)
Missed
- Guided improved performance in Q1FY26 → delivered ₹19.37 Cr loss vs ₹1.11 Cr profit (= MISS)
- Guided improved sugar recoveries → delivered 9.54% net recovery vs 11.73% YoY (= MISS)
Earnings Call filed with NSE, NSE: DBOL. Summary written with AI assistance from the document.
Dhampur Bio Organics Ltd: key numbers
- Share price
- ₹138.94
- Market cap
- ₹922.4 Cr
- Revenue (annual)
- ₹2,109 Cr
- Net profit (annual)
- ₹25.18 Cr
- P/E (TTM)
- 11.0×Sector 29.0×
- Promoter holding
- 51.00%+0.22% QoQ
- FII holding
- 0.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dhampur Bio Organics Ltd
All →Dhampur Bio Organics Board Meeting Date
Dhampur Bio Organics has scheduled a board meeting for 14 November 2026 to approve audited results and a share buyback proposal. The trading window stays closed until 16 November 2026.
Dhampur Bio Organics Management Change
Dhampur Bio Organics' VP Financial Planning and Analysis, Harmeet Singh, resigned, effective October 31, 2026. It is a senior management departure.
Dhampur Bio Organics Management Change
Dhampur Bio Organics Limited announced the cessation of Mr. Surendra Rai Kapur as Cost Auditor due to his demise, effective October 19, 2026.
Dhampur Bio Organics Partnership
Dhampur Bio Organics entered a technology licensing agreement with Planetary SA to produce Mycoprotein, with future plans for a joint venture and offtake agreement.
- Execution
- 10 years
Dhampur Bio Organics Capacity Expansion
Dhampur Bio Organics Ltd. executed a Technology Licensing Agreement with Planetary SA to produce Mycoprotein in India, introducing a new business segment and revenue stream.
Dhampur Bio Organics Other Announcement
The company submitted the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.